Dimitris Repantis1,2, Leonore Bovy3, Kathrin Ohla4, Simone Kühn5,6, Martin Dresler3. 1. Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Hindenburgdamm 30, 12203, Berlin, Germany. dimitris.repantis@charite.de. 2. Lise Meitner Group for Environmental Neuroscience, Max Planck Institute for Human Development, Berlin, Germany. dimitris.repantis@charite.de. 3. Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands. 4. Institute of Neuroscience and Medicine (INM-3), Jülich Research Centre, Jülich, Germany. 5. Lise Meitner Group for Environmental Neuroscience, Max Planck Institute for Human Development, Berlin, Germany. 6. Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
Abstract
RATIONAL: At all times humans have made attempts to improve their cognitive abilities by different means, among others, with the use of stimulants. Widely available stimulants such as caffeine, but also prescription substances such as methylphenidate and modafinil, are being used by healthy individuals to enhance cognitive performance. OBJECTIVES: There is a lack of knowledge on the effects of prescription stimulants when taken by healthy individuals (as compared with patients) and especially on the effects of different substances across different cognitive domains. METHODS: We conducted a pilot study with three arms in which male participants receivedplacebo and one of three stimulants (caffeine, methylphenidate, modafinil) and assessed cognitive performance with a test battery that captures various cognitive domains. RESULTS: Our study showed some moderate effects of the three stimulants tested. Methylphenidate had positive effects on self-reported fatigue as well as on declarative memory 24 hours after learning; caffeine had a positive effect on sustained attention; there was no significant effect of modafinil in any of the instruments of our test battery. All stimulants were well tolerated, and no trade-off negative effects on other cognitive domains were found. CONCLUSIONS: The few observed significant positive effects of the tested stimulants were domain-specific and of rather low magnitude. The results can inform the use of stimulants for cognitive enhancement purposes as well as direct further research to investigate the effects of stimulants on specific cognitive domains that seem most promising, possibly by using tasks that are more demanding.
RCT Entities:
RATIONAL: At all times humans have made attempts to improve their cognitive abilities by different means, among others, with the use of stimulants. Widely available stimulants such as caffeine, but also prescription substances such as methylphenidate and modafinil, are being used by healthy individuals to enhance cognitive performance. OBJECTIVES: There is a lack of knowledge on the effects of prescription stimulants when taken by healthy individuals (as compared with patients) and especially on the effects of different substances across different cognitive domains. METHODS: We conducted a pilot study with three arms in which male participants received placebo and one of three stimulants (caffeine, methylphenidate, modafinil) and assessed cognitive performance with a test battery that captures various cognitive domains. RESULTS: Our study showed some moderate effects of the three stimulants tested. Methylphenidate had positive effects on self-reported fatigue as well as on declarative memory 24 hours after learning; caffeine had a positive effect on sustained attention; there was no significant effect of modafinil in any of the instruments of our test battery. All stimulants were well tolerated, and no trade-off negative effects on other cognitive domains were found. CONCLUSIONS: The few observed significant positive effects of the tested stimulants were domain-specific and of rather low magnitude. The results can inform the use of stimulants for cognitive enhancement purposes as well as direct further research to investigate the effects of stimulants on specific cognitive domains that seem most promising, possibly by using tasks that are more demanding.
Authors: Wilson M Compton; Beth Han; Carlos Blanco; Kimberly Johnson; Christopher M Jones Journal: Am J Psychiatry Date: 2018-04-16 Impact factor: 18.112
Authors: Martin Dresler; Anders Sandberg; Kathrin Ohla; Christoph Bublitz; Carlos Trenado; Aleksandra Mroczko-Wąsowicz; Simone Kühn; Dimitris Repantis Journal: Neuropharmacology Date: 2012-07-22 Impact factor: 5.250
Authors: Martin Dresler; William R Shirer; Boris N Konrad; Nils C J Müller; Isabella C Wagner; Guillén Fernández; Michael Czisch; Michael D Greicius Journal: Neuron Date: 2017-03-08 Impact factor: 17.173
Authors: Patrick C Dolder; Felix Müller; Yasmin Schmid; Stefan J Borgwardt; Matthias E Liechti Journal: Psychopharmacology (Berl) Date: 2017-05-27 Impact factor: 4.530
Authors: Andrea Antal; Bruce Luber; Anna-Katharine Brem; Marom Bikson; Andre R Brunoni; Roi Cohen Kadosh; Veljko Dubljević; Shirley Fecteau; Florinda Ferreri; Agnes Flöel; Mark Hallett; Roy H Hamilton; Christoph S Herrmann; Michal Lavidor; Collen Loo; Caroline Lustenberger; Sergio Machado; Carlo Miniussi; Vera Moliadze; Michael A Nitsche; Simone Rossi; Paolo M Rossini; Emiliano Santarnecchi; Margitta Seeck; Gregor Thut; Zsolt Turi; Yoshikazu Ugawa; Ganesan Venkatasubramanian; Nicole Wenderoth; Anna Wexler; Ulf Ziemann; Walter Paulus Journal: Clin Neurophysiol Pract Date: 2022-05-25
Authors: Madeleine Michaëlsson; Shuai Yuan; Håkan Melhus; John A Baron; Liisa Byberg; Susanna C Larsson; Karl Michaëlsson Journal: BMC Med Date: 2022-04-11 Impact factor: 8.775
Authors: Antonio Verduzco-Mendoza; Paul Carrillo-Mora; Alberto Avila-Luna; Arturo Gálvez-Rosas; Adriana Olmos-Hernández; Daniel Mota-Rojas; Antonio Bueno-Nava Journal: Front Neurosci Date: 2021-06-24 Impact factor: 4.677